4//SEC Filing
Klowden Michael 4
Accession 0001104659-24-024187
CIK 0001845459other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 8:11 PM ET
Size
5.7 KB
Accession
0001104659-24-024187
Insider Transaction Report
Form 4
Klowden Michael
Director
Transactions
- Award
Stock Option (right to buy)
2024-02-12+300,000→ 300,000 totalExercise: $1.62→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]On February 12, 2024, the reporting person was granted 300,000 options pursuant to the Company's 2023 Equity Incentive Plan, vesting in equal installments on the first of each month, beginning October 1, 2023, and ending October 1, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
Documents
Issuer
NKGen Biotech, Inc.
CIK 0001845459
Entity typeother
Related Parties
1- filerCIK 0001991117
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 8:11 PM ET
- Size
- 5.7 KB